Metaflu

Sodium fluoride, the active ingredient in Metaflu, is a fluoride presented as an intravenous solution for intravenous use. It helps prevent dental caries and treats fluoride deficiency in patients requiring systemic supplementation. GNH USA supplies Metaflu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metaflu is used within the fluoride therapeutic class to address conditions that benefit from systemic fluoride supplementation. - Dental caries prevention: provides systemic fluoride to strengthen enamel and reduce decay risk. - Fluoride deficiency treatment: restores normal fluoride levels in individuals with inadequate dietary intake. - Adjunct in osteoporosis management: supplies fluoride ions that may support bone mineralization under specialist supervision.

Fluoride administration can be associated with a range of adverse reactions.

Common Side Effects: - Nausea: mild gastrointestinal discomfort. - Metallic taste: transient alteration in oral sensation. - Local irritation: redness or pain at the injection site. - Headache: mild to moderate intensity. - Low serum calcium: mild hypocalcemia in susceptible individuals.

Serious or Rare Side Effects: - Acute fluoride toxicity: symptoms may include vomiting, abdominal pain, and cardiac arrhythmias. - Severe hypocalcemia: can lead to tetany or seizures. - Anaphylactic reaction: rare but possible systemic allergic response. - Renal impairment: fluoride accumulation in patients with reduced kidney function.

When using Metaflu, consider the following safety measures. - Assess baseline fluoride status: evaluate dietary intake and existing fluoride exposure. - Monitor serum calcium: watch for signs of hypocalcemia during therapy. - Adjust dose in renal impairment: reduce dosage or increase monitoring frequency. - Avoid concurrent high‑dose fluoride products: prevent cumulative toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Fluoride can interact with several medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Calcium supplements: may reduce fluoride absorption and increase risk of hypocalcemia. - Aluminum-containing antacids: can form insoluble complexes, decreasing fluoride bioavailability.

Moderate Interactions (Monitor Closely): - Vitamin D analogues: may enhance calcium and phosphate shifts, necessitating electrolyte monitoring. - Loop diuretics: increase renal excretion of fluoride, potentially reducing efficacy. - Anticonvulsants (e.g., phenobarbital): may alter fluoride metabolism, requiring periodic serum level checks.